Chronic Kidney Disease in Pregnancy
On this page
Direct answer
From mild renal impairment with near-normal outcomes to advanced disease threatening mother and fetus, chronic kidney disease in pregnancy spans a spectrum on which the risk of pre-eclampsia, fetal growth restriction, preterm birth and accelerated loss of maternal renal function rises steeply. Prognosis tracks baseline renal function — a serum creatinine below about 1.4 mg/dL with minimal proteinuria generally allows a good outcome, whereas creatinine above 1.4 mg/dL (CKD stages 3-5) carries substantially higher maternal and fetal risk. Management is prepregnancy counselling, low-dose aspirin for pre-eclampsia prophylaxis, strict blood pressure control with pregnancy-safe drugs, serial growth scans with Doppler, and avoidance of nephrotoxins including ACE inhibitors, ARBs and NSAIDs.
What you must remember
- Risk gradient — women with CKD stage 1-2 (creatinine under 1.4 mg/dL, proteinuria under 1 g/day) usually do well; stage 3-5 face pre-eclampsia rates of 25-40 per cent or more, FGR, preterm delivery and a real risk of permanent renal decline.
- Proteinuria above 1 g/day, uncontrolled hypertension and baseline GFR below 40 mL/min are the strongest predictors of poor outcome.
- Superimposed pre-eclampsia is common and hard to diagnose — a doubling of proteinuria with rising creatinine, new hypertension or HELLP features should trigger suspicion rather than dismissal as "baseline".
- Safe antihypertensives — labetalol, methyldopa and nifedipine; contraindicated — ACE inhibitors, angiotensin receptor blockers (teratogenic, fetotoxic later) and NSAIDs.
- Low-dose aspirin (75-150 mg at night from 12 weeks) is recommended for pre-eclampsia prophylaxis in CKD; anaemia is managed with iron and erythropoietin.
- Dialysis patients rarely conceive and face high loss rates; intensifying dialysis to 20-36 or more hours per week dramatically improves live births — "more dialysis is better" is the exam summary.
- Renal transplant recipients should delay pregnancy 1-2 years with stable graft function (creatinine ideally under 1.5 mg/dL); azathioprine, tacrolimus and cyclosporin continue, while mycophenolate mofetil is absolutely contraindicated.
- Fetal surveillance — growth scans every 2-4 weeks from 26-28 weeks with umbilical artery Doppler, because placental insufficiency is the dominant fetal threat.
A structured clinic-to-delivery approach
Take a 26-year-old with IgA nephropathy, creatinine 1.2 mg/dL, proteinuria 800 mg/day on labetalol, booking at 8 weeks. Counselling first: her chance of a live birth is good, but she should expect close surveillance and a higher likelihood of iatrogenic preterm delivery. Baseline assessment includes creatinine with eGFR, quantitative proteinuria, haemoglobin, potassium, bicarbonate and urine culture; her ACE inhibitor has already been swapped for labetalol before conception — that swap is the single most asked preconception step.
She starts aspirin 150 mg at night from 12 weeks. Visits are combined obstetric-renal every 2-4 weeks: blood pressure treated persistently above 140/90 (targets commonly 110-140/85), proteinuria quantified periodically, and anaemia corrected with iron and erythropoietin if needed. From 26 weeks, growth scans with Doppler every three weeks watch for restriction; a falling growth trajectory with rising Doppler resistance dictates earlier delivery and corticosteroids for lung maturity.
The crunch decision comes at 34 weeks when her proteinuria doubles and blood pressure climbs despite three drugs — superimposed pre-eclampsia is diagnosed on the trend, magnesium sulphate prophylaxis is started, and delivery is planned once steroids are complete. Postpartum, she must not be lost to follow-up: NSAIDs are avoided, ACE inhibitors can be resumed after delivery even during breastfeeding, and renal function is rechecked at 6 weeks because the puerperium can unmask permanent decline.
High-yield viva angles
Viva examiners probe three corners. Which drugs change at the positive test — stop ACE inhibitors and ARBs, switch to labetalol, methyldopa or nifedipine. What makes a solitary or transplanted kidney behave differently — the hyperfiltration of a single or scarred kidney, which is why living kidney donors and nephrectomy patients face slightly higher pre-eclampsia rates. And how transplants are handled — timing 1-2 years post-graft, continued calcineurin inhibitors, mycophenolate stopped well before conception with a switch to azathioprine. A favourite one-liner: chronic glomerulonephritis with normal function and no hypertension carries a prognosis close to normal pregnancy.
Frequently asked questions
At what level of serum creatinine does pregnancy risk rise sharply?
Above about 1.4 mg/dL (roughly CKD stage 3 onwards), the risks of pre-eclampsia, FGR, preterm birth and irreversible renal decline increase substantially.
Which antihypertensives are safe in pregnancy with CKD?
Labetalol, methyldopa and nifedipine; ACE inhibitors, ARBs and NSAIDs are contraindicated during pregnancy.
Why is dialysis intensified in pregnant dialysis patients?
Longer and more frequent dialysis (often more than 20-36 hours per week) controls uraemia and volume, improving fetal survival markedly compared with standard schedules.
Can a renal transplant recipient have a safe pregnancy?
Yes, if graft function is stable (creatinine ideally under 1.5 mg/dL), pregnancy is deferred 1-2 years, blood pressure is controlled and mycophenolate is replaced by azathioprine.
How is pre-eclampsia suspected in a woman with baseline proteinuria?
By a rising trend — doubling of proteinuria, new or worsening hypertension, rising creatinine, low platelets or abnormal liver enzymes — rather than any single threshold value.